# SyReTo adoption of Agent Execution Discipline v1.1

**Status:** PASSIVE ADOPTION — TERMINAL EVIDENCE NOT ESTABLISHED

## Authority

The pinned shared standard is:

- path: `docs/standards/AGENT_EXECUTION_DISCIPLINE_v1.1.md`;
- version: `1.1`;
- SHA-256: `e79cad59a54f45d4dddc4335db543634563c9388b1310bc225b1e451eb6d2940`;
- upstream status: `Canonical internal standard`, dated 2026-09-26.

The adjacent `.sha256` file records the same byte identity. The pinned standard
is a vendor copy and must not be edited locally. SyReTo-specific applicability
is defined only by this adoption record.

## Why adoption is passive

Section 9 of the shared standard requires passive adoption while the protected
SyReTo Arm A r1 baseline remains non-terminal, and requires actual terminal
evidence before migration of that execution boundary.

Before this adoption, the current default branch and accessible commit history
were checked for the named evidence surface, including `Arm A`,
`PIPELINE_STATE`, `SOURCE_CONTEXT`, a frozen r1 marker, and a recorded
terminal checkpoint. No such terminal evidence was found.

Absence of those records in the inspected repository is not proof that the
protected baseline is terminal, nor proof that the boundary never existed.
Therefore this adoption fails closed: it does not activate or retrofit Level 2
runtime machinery into an existing review execution.

## Existing SyReTo substrate

SyReTo already has substantial deterministic and reproducibility-oriented
infrastructure, including:

- a git-native, file-based review pipeline;
- canonical package ownership in `syreto/`;
- explicit review configuration and execution contracts;
- deterministic status and validation surfaces;
- provenance sidecars and artifact catalogs;
- observability and recovery/rerun semantics;
- integrity guards and repository tests;
- contributor Git synchronization and verified publication through
  `scripts/task_sync.py`.

This adoption does not replace or duplicate those mechanisms.

## Protected boundary

Merely adopting the shared standard must not:

- move, refactor, regenerate, or reinterpret an existing protected review
  execution substrate;
- change prompts, dependencies, inputs, scheduling, guards, evaluation
  semantics, or output contracts of a protected run;
- add a new pipeline state machine or context-pack layer in front of an active
  or frozen review execution;
- convert existing operational artifacts into new research evidence;
- change canonical inputs or generated-artifact semantics.

Ordinary bounded maintenance outside a protected run remains governed by the
existing SyReTo development and reproducibility contracts.

## Implemented now

This passive adoption adds only:

1. a byte-identical pinned copy of Agent Execution Discipline v1.1;
2. its recorded SHA-256;
3. this SyReTo-specific adoption record;
4. short pointers from `AGENTS.md` and `CLAUDE.md`.

No review runtime, package logic, orchestration, inputs, outputs, prompts,
dependencies, scheduling, guards, or evaluation semantics are changed.

## Deferred activation

Active migration of the protected SyReTo execution boundary remains deferred
until there is a recorded terminal checkpoint for the protected baseline,
followed by a separate prospective migration change.

If the repository owner determines that the named protected baseline never
applied to this repository, that conclusion should itself be recorded explicitly
before treating the passive boundary as cleared; it must not be inferred merely
from missing search results.

Only after that boundary is resolved may a separate change assess whether
additional Level 2 mechanics are actually needed beyond SyReTo's existing
deterministic substrate.

## Validation boundary

This adoption is documentation/governance only. It does not claim that a new
Level 2 execution implementation has been validated.

Acceptance requires the repository's normal checks, including the existing test
suite and pre-commit/CI surfaces. Passing those checks establishes repository
consistency only; it does not establish terminal state for a protected review
run or scientific validity.
